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Abstract 
Background 
The National Institute for Health and Clinical Excellence (NICE) guidelines for multiple 
sclerosis (MS) recommend the time from initial presentation to first neurological evaluation to 
be no longer than 6 weeks, and a further six weeks until any necessary investigations are 
completed. The aim of this study was to evaluate how many patients with MS are diagnosed 
within the NICE timelines in two settings specific for Croatia.  
Patients and methods 
All patients with the final diagnosis of clinically isolated syndrome (CIS) or MS in a six 
months period were retrospectively reviewed. We calculated time from first symptom to first 
neurological evaluation, time from first symptom to MRI scan, time from first neurological 
evaluation to MRI scan, time from first neurological evaluation to lumbar puncture (LP), time 
from first symptom to diagnosis and time from first neurological evaluation to diagnosis. We 
also calculated the percentage of patients fulfilling the NICE timelines. 
Results 
This study showed that only 61.5% of MS patients in Croatia see neurologist within 6 weeks 
of first symptoms, and 64.1% are diagnosed within next 6 weeks. However, 80% and 100% of 
patients presented to the emergency room of our hospital (where a visit to a MS clinic can be 
automatically made) met the NICE guidelines for time from first symptom to first 
neurological evaluation and time from first neurological evaluation to diagnosis, respectively. 
Conclusion 
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 A specifically designed demyelinating disease diagnostic clinic offers a better service than 
other existing models in the diagnosis and management of MS patients. 
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Introduction 
The National Institute for Health and Clinical Excellence (NICE) guidelines for multiple 
sclerosis (MS) recommend the time from initial presentation to first neurological evaluation to 
be no longer than 6 weeks, and a further six weeks until any necessary investigations are 
completed. [1] The aim of this study was to evaluate the time from first clinical presentation, 
first neurological evaluation, MRI, lumbar puncture and final diagnosis in a specialized MS 
clinic in Croatia and to calculate how many patients are diagnosed within timlines in two 
settings specific for Croatia. 
 
Patients and methods 
All patients with the final diagnosis of clinically isolated syndrome (CIS) or MS in a six 
months period (April-October 2011) who were treated in the Referral Center for 
Demyelinating Diseases of the Central Nervous System in Zagreb were retrospectively 
reviewed. The diagnosis of CIS and MS was based on the 2010 revision of the McDonald’s 
criteria.[2] Data on clinical symptoms, type of first presentation (optic neuritis, transverse 
myelitis, brainstem/cerebellar symptoms, hemispheral symptoms and multifocal symptoms), 
final diagnosis (CIS, RRMS, PPMS), CFS findings, number of lesions on the brain MRI and 
VEP findings were gathered. We calculated time from first symptom to first neurological 
evaluation, time from first symptom to MRI scan, time from first neurological evaluation to 
MRI scan, time from first neurological evaluation to lumbar puncture (LP), time from first 
symptom to diagnosis and time from first neurological evaluation to diagnosis. We also 
calculated the percentage of patients fulfilling the NICE timelines. Furthermore we divided 
patients in two groups. The first group consisted of patients who presented to the emergency 
room of our Department of Neurology and the second group consisted of patients who were 
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referred to our Center outpatient clinic from other regional hospitals or general practitioners. 
The differences between groups for all parameters were calculated by using t-test for 
independent samples. P value < 0.05 was considered as statistically significant. For the 
statistics SPSS (Chicago, Il) software was used. 
 
Results 
In the study period we identified 39 patients, 26 females and 13 males. There were 5 patients 
with optic neuritis, 8 with transverse myelitis, 15 with brainstem/cerebellar symptoms, 6 with 
hemispheral symptoms and 5 with multifocal symptoms. The diagnosis of RRMS was made 
in 16, PPMS in 1 and CIS in 22 patients. Brain MRI was normal in one patient, 3 had one 
lesion and 35 patients had more than 2 lesions. CSF analysis revealed oligoclonal bands in all 
patients and VEP was positive in 15 patients. 
In table 1 data on all analyzed parameters are presented. The mean time from first symptom to 
first neurological evaluation was 21.5 weeks. NICE guidelines were fulfilled only for 24 
(61.5%) patients.  The reasons for delayed initial neurological evaluation were unrecognized 
clinical symptoms by general practitioner (GP) resulting in the delayed referral, non-specific 
symptoms resulting either in patients not seeking medical attention on time or delayed referral 
by the GP, patient not attending the first appointment and scheduling difficulties due to 
staffing shortages. The mean time from first neurological evaluation to MRI scan was 4.2 
weeks. MRI scan was performed before first neurological visit in 13 (33.3%) patients. Only 4 
patients had MRI scan performed more than 6 weeks after the initial neurological evaluation, 
one because he failed to attend the MRI appointment, two because they were not referred to 
the MRI by the neurologist because of unspecific clinical symptoms and one because of 
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scheduling difficulties. Reasons for the delay in CSF analysis were the same as for the delay 
in MRI. 
The mean time from first symptom to diagnosis was 34.3 weeks and time from first 
neurological evaluation to diagnosis was 12.8 weeks. NICE guidelines were fulfilled only for 
24 (61.5%) patients.  The main reasons were due to delayed MRI or LP and clerical errors. 
When we divided the patients in two groups, there were 10 patients in the group 1 and 29 
patients in group 2 (Table 2).There was a statistically significant difference between groups in 
time from first symptom to first neurological evaluation, time from first symptom to MRI 
scan and time from first symptom to diagnosis. When looking at time from first symptom to 
first neurological evaluation and time from first neurological evaluation to diagnosis, NICE 
guidelines were fulfilled for 80.0% and 100.0% of patients in group 1 and 55.2% and 51.7% 
in group 2, respectively. 
 
Discussion 
This study showed that only 61.5% of MS patients in Croatia see a neurologist within 6 weeks 
of first symptoms, and 64.1% are diagnosed within next 6 weeks. When considering these 
results specific condition of the Croatian healthcare system should be taken into account. The 
patients with neurological symptoms can without referral from a GP or emergency medicine 
specialist see a neurologist in an emergency room of a hospital that has a neurological service. 
This is the reason why we divided the patients into two groups. Although there was no 
difference between groups after the initial neurological evaluation (time to MRI, LP or 
diagnosis), 80% and 100% of patients presented to the emergency room of our hospital 
(where a visit to a MS clinic can be automatically made) met the NICE guidelines for time 
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from first symptom to first neurological evaluation and time from first neurological evaluation 
to diagnosis, respectively. 
Compared to other European countries, time from first symptom to first neurological 
evaluation is longer in Croatia than in Ireland (NICE guidelines were met for 61.5% versus 
78% patients) while time from first neurological evaluation and final diagnosis is shorter in 
Croatia than Ireland (NICE guidelines were met for 64.1% versus 52% patients).[3] On the 
other hand for Spanish versus Croatian MS patients both intervals are longer (median time of 
15.6 versus 2 and 7.2 versus 2.3 weeks, respectively).[4] The reasons for these differences 
should be sought for in different organization of health care systems in Europe, but also in MS 
awareness among GPs and emergency medicine physicians. As well, our study supported the 
finding that specifically designed demyelinating disease diagnostic clinic offers a better 
service than other existing models.[5] 
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Tables 
Table 1. Overall times from presentation to diagnosis. 
 Mean time 
(weeks) 
Median time 
(weeks) 
Range (weeks) Number (%) fulfilling 
NICE guidelines 
Time from first symptom 
to first neurological 
evaluation 
21.5 2 0-204.4 24 (61.5%) 
Time from first symptom 
to MRI scan 
25.7 5.1 0.3-206.9 NA 
Time from first 
neurological evaluation to 
MRI scan 
4.2 0.6 -10.1-100.9 NA 
Time from first 
neurological evaluation to 
LP 
11.3 1.1 0-197.7 NA 
Time from first symptom 
to diagnosis 
34.3 9.7 1.1-209.9 NA 
Time from first 
neurological evaluation to 
diagnosis 
12.8 2.3 0.4-198.7 25 (64.1%) 
 
 
Table 2. Comparison of analyzed parameters between groups. 
 Group Mean time (weeks) p value Number (%) fulfilling 
NICE guidelines 
Time from first symptom to first 
neurological evaluation 
1 3.6 0.021 8 (80.0%) 
2 27.7 16 (55.2%) 
Time from first symptom to MRI 
scan 
1 4.3 0.008 NA 
2 33.1 NA 
Time from first neurological 
evaluation to MRI scan 
1 0.7 0.448 NA 
2 5.4 NA 
Time from first neurological 
evaluation to LP 
1 0.8 0.278 NA 
2 14.9 NA 
Time from first symptom to 
diagnosis 
1 5.5 0.002 NA 
2 44.2 NA 
Time from first neurological 
evaluation to diagnosis 
1 1.9 0.259 10 (100.0%) 
2 16.5 15 (51.7%) 
 
